AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16500175 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal physical activity)
Number of subjects: 36
Study 12733850 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium oxybate (3-9 gm/night)
Number of subjects: 55
Study 12733850 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 11072779 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine supplementation (5 g creatine monohydrate, four times daily for 7 days)
Number of subjects: 36
Study 11072779 — intervention group
Group type: COMPARATOR
Intervention: Placebo (glucose capsules, same number as CS)
Number of subjects: 36
Study 11072779 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine supplementation
Number of subjects: 36
Study 11072779 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 9566142 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser irradiated group (LG)
Number of subjects: 0
Study 9566142 — intervention group
Group type: COMPARATOR
Intervention: Blind irradiation group (BG)
Number of subjects: 0
Study 9566142 — intervention group
Group type: COMPARATOR
Intervention: Non-treated control group (CG)
Number of subjects: 0
Study 8468527 — intervention group
Group type: COMPARATOR
Intervention: High cholesterol diet (HC): 320 mg cholesterol/1000 kcal
Number of subjects: 30
Study 3511944 — intervention group
Group type: EXPERIMENTAL
Intervention: new hydrocolloid dressing plus compression
Number of subjects: 34
Study 3511944 — intervention group
Group type: COMPARATOR
Intervention: double layer bandage (inner paste bandage with zinc oxide paste and outer elastic bandage)
Number of subjects: 34
Study 29070627 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (tDCS) to the left motor cortex
Number of subjects: 16
Study 29070627 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation (Control)
Number of subjects: 16
Study 27110529 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (0.25 mg/kg) with paracetamol (15 mg/kg)
Number of subjects: 0
Study 27110529 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol (15 mg/kg) alone
Number of subjects: 0
Study 24566243 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.03 mg/kg midazolam
Number of subjects: 90
Study 24566243 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05 mg/kg midazolam
Number of subjects: 90
Study 24566243 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 90
Study 21993613 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined peer-expert narrative intervention
Number of subjects: 404
Study 21993613 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 404
Study 20490906 — intervention group
Group type: EXPERIMENTAL
Intervention: Terutroban
Number of subjects: 1100
Study 20490906 — intervention group
Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 1100
Study 17709109 — intervention group
Group type: EXPERIMENTAL
Intervention: rosuvastatin 40 mg/day for 4 weeks
Number of subjects: 25
Study 17709109 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 25
Study 15796635 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-solving skills training (PSST), 8 sessions
Number of subjects: 430
Study 15796635 — intervention group
Group type: COMPARATOR
Intervention: Usual psychosocial care (UPC)
Number of subjects: 430
Study 12370562 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish Oil (FO) 1.8 g of omega‐3 fatty acids x d(‐1)
Number of subjects: 22
Study 12370562 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflavones (ISO) 120 mg soy isolate x d(‐1)
Number of subjects: 22
Study 12370562 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL) (Western fat blend and/or wheat flour)
Number of subjects: 22
Study 10583448 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin pretreatment (3 mg) plus smoking
Number of subjects: 0
Study 10583448 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol pretreatment (50 mg) plus smoking
Number of subjects: 0
Study 10583448 — intervention group
Group type: COMPARATOR
Intervention: Placebo pretreatment plus smoking
Number of subjects: 0
Study 8915027 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-mouth disinfection (scaling and rootplaning in 2 visits within 24 h, tongue brushing with 1% chlorhexidine gel for 1 min, mouth rinsing with 0.2% chlorhexidine solution for 2 min, subgingival irrigation with 1% chlorhexidine gel)
Number of subjects: 10
Study 8915027 — intervention group
Group type: COMPARATOR
Intervention: Control group (scaling and rootplaning at a 2-week interval)
Number of subjects: 10
Study 8915027 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-mouth disinfection
Number of subjects: 10
Study 1908493 — intervention group
Group type: EXPERIMENTAL
Intervention: GHRH (1 microgram/kg iv)
Number of subjects: 22
Study 1908493 — intervention group
Group type: EXPERIMENTAL
Intervention: TRH (400 microgram iv)
Number of subjects: 22
Study 1908493 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 6351890 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorpheniramine (4 mg)
Number of subjects: 14
Study 6351890 — intervention group
Group type: EXPERIMENTAL
Intervention: Clemastine (1 mg)
Number of subjects: 14
Study 6351890 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 31387410 — intervention group
Group type: EXPERIMENTAL
Intervention: Fulranumab 3 mg Q4wk
Number of subjects: 245
Study 31387410 — intervention group
Group type: EXPERIMENTAL
Intervention: Fulranumab 1 mg Q4wk
Number of subjects: 245
Study 31387410 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 245
Study 28719500 — intervention group
Group type: EXPERIMENTAL
Intervention: DTaP-IPV-HB-PRP-T vaccine
Number of subjects: 1375
Study 28719500 — intervention group
Group type: COMPARATOR
Intervention: Control vaccine (DTaP-HB-IPV//PRP-T)
Number of subjects: 1375
Study 28719500 — intervention group
Group type: EXPERIMENTAL
Intervention: Antipyretics
Number of subjects: 1375
Study 28719500 — intervention group
Group type: EXPERIMENTAL
Intervention: Extra (oral) polio vaccination
Number of subjects: 1375
Study 28719500 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV7 and rotavirus vaccine
Number of subjects: 1375
Study 26595100 — intervention group
Group type: EXPERIMENTAL
Intervention: Average change across visits in mean 2-hour blood glucose level after meals
Number of subjects: 1115
Study 26595100 — intervention group
Group type: EXPERIMENTAL
Intervention: Average change across visits in hemoglobin A1c level
Number of subjects: 1115
Study 26595100 — intervention group
Group type: EXPERIMENTAL
Intervention: Absence of a history of stroke or acute MI
Number of subjects: 1115
Study 26595100 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting blood glucose and randomized insulin treatment strategy
Number of subjects: 1115
Study 25079933 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5 mg prednisolone daily for 2 years (P-group; n=108)
Number of subjects: 225
Study 25079933 — intervention group
Group type: COMPARATOR
Intervention: No prednisolone (NoP-group; n=117)
Number of subjects: 225
Study 21503648 — intervention group
Group type: EXPERIMENTAL
Intervention: Target preview delay of 150 ms before perturbation onset
Number of subjects: 0
Study 21503648 — intervention group
Group type: EXPERIMENTAL
Intervention: Target preview delay of 70 ms
Number of subjects: 0
Study 21503648 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-latency epoch (R1; 20-45 ms)
Number of subjects: 0
Study 21503648 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-latency epoch (45-105 ms)
Number of subjects: 0
Study 21503648 — intervention group
Group type: EXPERIMENTAL
Intervention: Voluntary epoch (120-180 ms)
Number of subjects: 0
Study 21503648 — intervention group
Group type: EXPERIMENTAL
Intervention: Target appeared after perturbation onset (target PD = +90 ms)
Number of subjects: 0
Study 19996018 — intervention group
Group type: EXPERIMENTAL
Intervention: TEVAR (Thoracic Endovascular Aortic Repair) in addition to optimal medical therapy (n=72)
Number of subjects: 140
Study 19996018 — intervention group
Group type: COMPARATOR
Intervention: Optimal medical therapy alone (n=68)
Number of subjects: 140
Study 19996018 — intervention group
Group type: EXPERIMENTAL
Intervention: TEVAR (Thoracic Endovascular Aortic Repair)
Number of subjects: 140
Study 19996018 — intervention group
Group type: COMPARATOR
Intervention: Optimal medical therapy alone
Number of subjects: 140
Study 19996018 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined end point of aorta-related death and progression (including conversion or additional endovascular or open surgery)
Number of subjects: 140
Study 17664199 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (15 mg x kg(‐1) before infusion of heparin and 15 mg x kg(‐1) after protamine infusion)
Number of subjects: 66
Study 17664199 — intervention group
Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 66
Study 17664199 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 66
Study 15548814 — intervention group
Group type: EXPERIMENTAL
Intervention: Niacin 500 mg
Number of subjects: 12
Study 15548814 — intervention group
Group type: EXPERIMENTAL
Intervention: Niacin 250 mg
Number of subjects: 12
Study 15548814 — intervention group
Group type: EXPERIMENTAL
Intervention: Niacin (both doses)
Number of subjects: 12
Study 15548814 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 11314677 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% daily dose of methadone
Number of subjects: 20
Study 11314677 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% daily dose of methadone
Number of subjects: 20
Study 11314677 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 11314677 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone (both doses)
Number of subjects: 20
Study 9213939 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative intervention
Number of subjects: 75
Study 9213939 — intervention group
Group type: COMPARATOR
Intervention: Soft-tissue operation (tenotomy)
Number of subjects: 75
Study 9213939 — intervention group
Group type: COMPARATOR
Intervention: Open neurolysis
Number of subjects: 75
Study 8200249 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide (1.25 micrograms/kg subcutaneously)
Number of subjects: 10
Study 8200249 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 2822203 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet with little or no sugar and high in unrefined carbohydrate
Number of subjects: 352
Study 2822203 — intervention group
Group type: COMPARATOR
Intervention: Diet unrestricted in sugar and low in fibre
Number of subjects: 352
Study 30189840 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical steroid
Number of subjects: 0
Study 30189840 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 27091900 — intervention group
Group type: EXPERIMENTAL
Intervention: ivabradine
Number of subjects: 46
Study 27091900 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 46
Study 25517733 — intervention group
Group type: EXPERIMENTAL
Intervention: 360 µg TNF-K (3 injections)
Number of subjects: 40
Study 25517733 — intervention group
Group type: EXPERIMENTAL
Intervention: TNF-K (all doses)
Number of subjects: 40
Study 25517733 — intervention group
Group type: COMPARATOR
Intervention: Placebo (3 injections)
Number of subjects: 40
Study 25517733 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with anti-TNF antibody response
Number of subjects: 40
Study 25517733 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients without anti-TNF antibody response
Number of subjects: 40
Study 22813832 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone support oriented by accelerometer measurements
Number of subjects: 29
Study 22813832 — intervention group
Group type: COMPARATOR
Intervention: Accelerometer (control group)
Number of subjects: 29
Study 22813832 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerometer (intervention group)
Number of subjects: 29
Study 20362199 — intervention group
Group type: EXPERIMENTAL
Intervention: Serotype 9V
Number of subjects: 0
Study 20362199 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-absorption using serotype 9V
Number of subjects: 0
Study 20362199 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumococcal conjugate vaccine (PCV) doses
Number of subjects: 0
Study 17845107 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-administered cognitive-behavioral therapy (T-CBT) for 16 weeks
Number of subjects: 0
Study 17845107 — intervention group
Group type: COMPARATOR
Intervention: Telephone-administered supportive emotion-focused therapy (T-SEFT) for 16 weeks
Number of subjects: 0
Study 15675924 — intervention group
Group type: EXPERIMENTAL
Intervention: Troposmia group (strawberry scented facemask with sevoflurane)
Number of subjects: 64
Study 15675924 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard facemask without olfactory modification)
Number of subjects: 64
Study 12025733 — intervention group
Group type: EXPERIMENTAL
Intervention: Multichannel recording of the interhemispheric amplitude distribution of the N70 of the onset VEP
Number of subjects: 47
Study 12025733 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrode pair over the temporo-parietal junction
Number of subjects: 47
Study 12025733 — intervention group
Group type: EXPERIMENTAL
Intervention: Cumulative abnormality taken over all lateral electrode pairs
Number of subjects: 47
Study 10400054 — intervention group
Group type: EXPERIMENTAL
Intervention: Idoxifene 2.5 mg/day
Number of subjects: 331
Study 10400054 — intervention group
Group type: EXPERIMENTAL
Intervention: Idoxifene 5 mg/day
Number of subjects: 331
Study 10400054 — intervention group
Group type: EXPERIMENTAL
Intervention: Idoxifene 10 mg/day
Number of subjects: 331
Study 10400054 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 331
Study 10400054 — intervention group
Group type: EXPERIMENTAL
Intervention: Idoxifene (all doses)
Number of subjects: 331
Study 7575066 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin alfa, 150 U/kg, administered subcutaneously three times per week for 6 weeks
Number of subjects: 25
Study 7575066 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin alfa, 150 U/kg, administered to patients who were originally receiving placebo for 6 weeks
Number of subjects: 25
Study 7575066 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered subcutaneously three times per week for 6 weeks
Number of subjects: 25
Study 1702338 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethamsylate (Dicynene)
Number of subjects: 44
Study 6249137 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrostimulation analgesia (ESA)
Number of subjects: 30
Study 6249137 — intervention group
Group type: COMPARATOR
Intervention: Neuroleptanalgesia (NLA)
Number of subjects: 30
Study 31880315 — intervention group
Group type: EXPERIMENTAL
Intervention: ROC-guided survival trees and ensembles
Number of subjects: 0
Study 31880315 — intervention group
Group type: EXPERIMENTAL
Intervention: Ensemble procedure based on averaging martingale estimating equations
Number of subjects: 0
Study 31875047 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-min treadmill running
Number of subjects: 40
Study 31875047 — intervention group
Group type: COMPARATOR
Intervention: Walking
Number of subjects: 40
Study 31875047 — intervention group
Group type: EXPERIMENTAL
Intervention: Running
Number of subjects: 40
Study 27862264 — intervention group
Group type: EXPERIMENTAL
Intervention: Every three-hour oral feeding schedule
Number of subjects: 55
Study 27862264 — intervention group
Group type: COMPARATOR
Intervention: Every six-hour oral feeding schedule
Number of subjects: 55
Study 25357148 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial body weight‐support treadmill training at 10% inclination
Number of subjects: 28
Study 25357148 — intervention group
Group type: COMPARATOR
Intervention: Partial body weight‐support treadmill training with no inclination
Number of subjects: 28
Study 23286782 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein and Ca drink (500 ml)
Number of subjects: 16
Study 23286782 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat milk
Number of subjects: 16
Study 23286782 — intervention group
Group type: COMPARATOR
Intervention: Control drink
Number of subjects: 16
Study 21079374 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral stress management program
Number of subjects: 124
Study 21079374 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 124
Study 19960160 — intervention group
Group type: EXPERIMENTAL
Intervention: Coitus
Number of subjects: 0
Study 19960160 — intervention group
Group type: EXPERIMENTAL
Intervention: Orgasm
Number of subjects: 0
Study 19960160 — intervention group
Group type: EXPERIMENTAL
Intervention: Coitus and Orgasm
Number of subjects: 0
Study 15930400 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized decision support tool
Number of subjects: 693
Study 15930400 — intervention group
Group type: COMPARATOR
Intervention: Memory-based triage by nurses
Number of subjects: 693
Study 12393770 — intervention group
Group type: EXPERIMENTAL
Intervention: Hextend
Number of subjects: 63
Study 12393770 — intervention group
Group type: COMPARATOR
Intervention: Lactated Ringers solution (RL)
Number of subjects: 63
Study 12393770 — intervention group
Group type: COMPARATOR
Intervention: HES 130/0.4
Number of subjects: 63
Study 10342804 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-enhanced, computer-assisted, self-administered interviews (V-CASI)
Number of subjects: 280
Study 10342804 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face interviews (FTFI)
Number of subjects: 280
Study 7773829 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive geriatric assessment
Number of subjects: 0
Study 2387608 — intervention group
Group type: EXPERIMENTAL
Intervention: Preanaesthetic medication with atropine and retrobulbar injection of xylocaine
Number of subjects: 53
Study 2387608 — intervention group
Group type: EXPERIMENTAL
Intervention: Preanaesthetic medication with atropine
Number of subjects: 53
Study 2387608 — intervention group
Group type: EXPERIMENTAL
Intervention: Retrobulbar injection of xylocaine
Number of subjects: 53
Study 2387608 — intervention group
Group type: COMPARATOR
Intervention: No preanaesthetic medication with atropine or retrobulbar block with xylocaine
Number of subjects: 53
Study 7104169 — intervention group
Group type: EXPERIMENTAL
Intervention: Food intake
Number of subjects: 6
Study 31945165 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-week participatory ergonomics intervention consisting of three training workshops
Number of subjects: 190
Study 31945165 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 190
Study 31945165 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-week participatory ergonomics intervention
Number of subjects: 190
Study 30817193 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal assessment including imaging characteristics and hormonal measurements
Number of subjects: 0
Study 30817193 — intervention group
Group type: EXPERIMENTAL
Intervention: Biopsy, surgical or medical therapy, and longitudinal surveillance
Number of subjects: 0
Study 28763464 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole
Number of subjects: 16
Study 28763464 — intervention group
Group type: COMPARATOR
Intervention: Simethicone and activated charcoal (SC; Carbosylane)
Number of subjects: 16
Study 25057116 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical discectomy
Number of subjects: 1244
Study 25057116 — intervention group
Group type: COMPARATOR
Intervention: Usual nonoperative care
Number of subjects: 1244
Study 25057116 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined randomized and observational cohorts (surgery)
Number of subjects: 1244
Study 25057116 — intervention group
Group type: COMPARATOR
Intervention: Combined randomized and observational cohorts (nonoperative care)
Number of subjects: 1244
Study 23431966 — intervention group
Group type: EXPERIMENTAL
Intervention: PUVA
Number of subjects: 36
Study 23431966 — intervention group
Group type: COMPARATOR
Intervention: PUVAsol
Number of subjects: 36
Study 21830265 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored patient preference intervention including educational and motivational components, simplified dosing regimes, and practical reminders (pill dispensers)
Number of subjects: 71
Study 21830265 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 71
Study 21830265 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored patient preference intervention
Number of subjects: 71
Study 19137306 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.0 T MRI
Number of subjects: 24
Study 19137306 — intervention group
Group type: COMPARATOR
Intervention: 1.5 T MRI
Number of subjects: 24
Study 17204318 — intervention group
Group type: EXPERIMENTAL
Intervention: Network-model managed care health plan
Number of subjects: 442
Study 17204318 — intervention group
Group type: COMPARATOR
Intervention: Community-based practices (CBP)
Number of subjects: 442
Study 17204318 — intervention group
Group type: EXPERIMENTAL
Intervention: Both strategies
Number of subjects: 442
Study 16246820 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck muscle endurance training
Number of subjects: 180
Study 16246820 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck muscle strength training
Number of subjects: 180
Study 16246820 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 180
Study 11755939 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental yoghurt (3 cups daily providing 1 g of plant stanols)
Number of subjects: 60
Study 11755939 — intervention group
Group type: COMPARATOR
Intervention: Placebo yoghurt (3 cups daily)
Number of subjects: 60
Study 11755939 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental yoghurt
Number of subjects: 60
Study 10523963 — intervention group
Group type: EXPERIMENTAL
Intervention: Deoxinate therapy
Number of subjects: 0
Study 10523963 — intervention group
Group type: COMPARATOR
Intervention: Enkad
Number of subjects: 0
Study 7537797 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormonal therapy
Number of subjects: 648
Study 1709002 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-isobutyl-1-methylxanthine (IBMX)
Number of subjects: 0
Study 1709002 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 0